AIDS- and sexuality-related stigmas underlying the use of post-exposure prophylaxis for HIV in Brazil: findings from a multicentric study

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Citação
SEXUAL AND REPRODUCTIVE HEALTH MATTERS, v.27, n.3, p.107-121, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
AIDS-related stigma is a major hurdle to care and it hinders people from accessing HIV prevention methods, such as post-exposure prophylaxis. This study was designed to explore how AIDS-related stigma impacts the experience of using non-occupational post-exposure prophylaxis (nPEP) for HIV after sexual contact. Data were gathered in in-depth interviews with 59 people who voluntarily sought out nPEP in five public healthcare facilities in Brazil between 2015 and 2016. Data were analysed into three thematic categories: fear of being mistaken for a person living with HIV and AIDS (PLWHA); desire to hide particular features of one's sexual life; and experiences of stigmatising behaviour due to nPEP use. Based on the Health Stigma and Discrimination Framework, predominant manifestations of AIDS-related stigma in each category were analysed, as well as their intersections with gender- and sexuality-related stigmas. Results show that experiences of using nPEP are permeated by AIDS-related stigma, intersecting with sexuality- and gender-related stigmas. Stigma experiences are mainly perceived, anticipated and internalised; stigma practices include prejudice and stigmatising behaviours. Taking antiretrovirals (ARVs) led participants to the fear of being discriminated against as a PLWHA and having particular features of their sexual identities disclosed. Thus, hiding nPEP was strategic to protect from stigmatising behaviour. As ARV-based prevention technologies are scaled-up, interventions designed to tackle AIDS- and sexuality-related stigmas must be expanded in Brazil. Required interventions include public campaigns about nPEP, educational programmes in healthcare settings to offer adequate support to nPEP users and investments in stigma research and monitoring.
Palavras-chave
<bold>s</bold>tigma, post-exposure prophylaxis, HIV, AIDS, prevention, qualitative research
Referências
  1. [Anonymous], 2018, B EP HIV AIDS 2018, P1
  2. Bastos FIPM, 2014, PESQUISA NACL USO CR
  3. Beloqui J, 2019, VIOLENCIA DISCRIMINA
  4. Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe
  5. Bird JDP, 2011, J HEALTH PSYCHOL, V16, P365, DOI 10.1177/1359105310379064
  6. Bird JDP, 2013, AM J PUBLIC HLTH
  7. Bird JDP, 2017, CULT HEAL SEX
  8. Ferraz D, 2016, B ABIA ASS BRAS INTE, V61, P9
  9. Ferraz Dulce, 2015, Rev. bras. epidemiol., V18, P89, DOI 10.1590/1809-4503201500050007
  10. Gamarel KE, 2018, AIDS BEHAV, V22, P522, DOI 10.1007/s10461-017-2005-1
  11. Goffman E., 1963, STIGMA NOTES MANAGEM
  12. Golub SA, 2018, CURR HIV-AIDS REP, V15, P190, DOI 10.1007/s11904-018-0385-0
  13. Goparaju Lakshmi, 2017, J AIDS Clin Res, V8, DOI 10.4172/2155-6113.1000730
  14. Grangeiro A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009021
  15. Grangeiro Alexandre, 2015, Rev. bras. epidemiol., V18, P43, DOI 10.1590/1809-4503201500050005
  16. Gruskin S, 2018, REPROD HEALTH MATTER, V26
  17. Jeffries WL, 2015, AIDS ED PREV
  18. Joint United Nations Programme on HIV/AIDS, 2010, COMB HIV PREV TAIL C
  19. Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640
  20. Keogh P, 2008, AIDS CARE, V20, P576, DOI 10.1080/09540120701867123
  21. Kerr L, 2018, MEDICINE, V97, pS9, DOI [10.1097/MD.0000000000010573, 10.1097/md.0000000000010573]
  22. King EJ, 2013, AIDS BEHAV, V17, P2597, DOI 10.1007/s10461-013-0447-7
  23. Kippax S, 2012, AM J PUBLIC HEALTH, V102, P789, DOI 10.2105/AJPH.2011.300594
  24. Maluwa M, 2001, HEALTH HUM RIGHTS, V6, P1
  25. Mey A, 2017, AIDS BEHAV, V21, P352, DOI 10.1007/s10461-016-1598-0
  26. Monteiro S, 2019, CAD SAUDE PUBLICA, V35
  27. Monteiro S, 2019, GLOB PUBLIC HEALTH, V14, P764, DOI 10.1080/17441692.2018.1545038
  28. MOSCOVICI S, 1988, EUR J SOC PSYCHOL, V18, P211, DOI 10.1002/ejsp.2420180303
  29. Oldenburg CE, 2015, AIDS, V29, P837, DOI 10.1097/QAD.0000000000000622
  30. Paiva V, 2012, VULNERABILIDADE DIRE, VI, P111
  31. Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0
  32. Parker R, 2018, STRUCTURAL INTERVENT
  33. Parker R, 2013, ORGANIZADORES ESTIGM, P25
  34. Parker R, 2001, EPITOME HIST MED, P1
  35. Pinheiro TF, 2015, CAMISINHA HOMOEROTIS
  36. Rateau P., 2011, HDB THEORIES SOCIAL, V2, P477, DOI 10.4135/9781446249222.N50
  37. Rubin GS, 1984, SOCIAL PERSPECTIVES, P100
  38. Rueda S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011453
  39. Seffner F, 2016, INTERFACE-BOTUCATU, V20, P293, DOI 10.1590/1807-57622015.0459
  40. Stangl AL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1271-3
  41. Stringer KL, 2016, AIDS BEHAV, V20, P115, DOI 10.1007/s10461-015-1256-y
  42. Szwarcwald CL, 2011, JAIDS-J ACQ IMM DEF, V57, pS129, DOI 10.1097/QAI.0b013e31821e9a36
  43. Tangmunkongvorakul A, 2013, AIDS CARE, V25, P961, DOI 10.1080/09540121.2012.748871
  44. Treichler PA, 1996, DISCIPLINARITY DISSE
  45. Turan JM, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1246-9
  46. United Nations General Assembly, 2016, POL DECL HIV AIDS FA
  47. Venturi G, 2011, DIVERSIDADE SEXUAL H, P190
  48. Villela WV, 2015, EPIDEMIOL SERV SAUDE, V24, P531, DOI 10.5123/S1679-49742015000300019
  49. Wanyenze RK, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0119-1
  50. Zucchi EM, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00206617, 10.1590/0102-311x00206617]